Gevorkian Medical Center is categorized under Family Practice Doctors in Los Angeles, CA and active since 1985.
Gevorkian Medical Center was established in 1985, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Rafayel Gevorkian at the company’s single location by writing to 5129 West Sunset Boulevard, Los Angeles, California CA 90027 or by phoning (323) 663-9009. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gevorkian Medical Center |
| Contact Person: | Rafayel Gevorkian |
| Address: | 5129 West Sunset Boulevard, Los Angeles, California 90027 |
| Phone Number: | (323) 663-9009 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1985 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Gevorkian Medical Center was started in 1985 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Rafayel Gevorkian for inquiries that concern Gevorkian Medical Center by calling the company number (323) 663-9009, as your correspondence is most welcome. Additionally, the physical location of the single location of Gevorkian Medical Center can be found at the coordinates 34.09816,-118.30155 as well as the street address 5129 West Sunset Boulevard in Los Angeles, California 90027.
For its online presence, you may visit Gevorkian Medical Center’s website at and engage with its social media outlets through on Twitter and on Facebook.